Literature DB >> 30147099

Comparison of conventional Pap smear and liquid-based cytology: A study of cervical cancer screening at a tertiary care center in Bihar.

Sangeeta Pankaj1, Syed Nazneen1, Simi Kumari1, Anjili Kumari1, Anita Kumari1, Jaya Kumari1, Vijayanand Choudhary2, Shishir Kumar3.   

Abstract

BACKGROUND: Cervical cancer is the fourth leading cause of cancer in women in the world and it is the second most common cancer in women 15-44 years of age. Strict implementation of screening programs has led to a large decrease in cervical cancer incidence and mortality in the developed countries. In contrast, cervical cancer remains largely uncontrolled in high-risk developing countries because of ineffective or no screening programs. Conventional Pap smear method has been the mainstay of most of the screening programs for many decades. However, this technique is not without limitations, and the sensitivity and specificity of cervical cytology are relatively low. To overcome the limitations of conventional Pap smear (CPS), liquid-based cytology (LBC) was introduced in 1990s as a better tool for processing cervical samples.
OBJECTIVES: This study was undertaken to compare CPS with liquid-based methods, to assess the effectiveness and feasibility of LBC over CPS in our setting, and also to evaluate the prevalence of human papillomavirus (HPV) in our population.
MATERIALS AND METHODS: This study was conducted in Gynecological Oncology Unit of Regional Cancer Center at Indira Gandhi Institute of Medical Sciences, Patna, Bihar. About 310 women were enrolled in this study and the sample was taken for both conventional cytology and LBC. The smears were studied in detail and were interpreted as per the Bethesda system of reporting Pap smears. The results were compared and analyzed statistically.
RESULTS: Unsatisfactory smears were more commonly reported by conventional method (7.1%) than with liquid-based method (1.61%), and this difference is statistically significant. There was no difference in the detection of epithelial cell abnormalities using both the methods. HPV DNA for high-risk oncogenic strains (16 and 18) was detected in 6.45% of women in this study.
CONCLUSION: LBC has been found to be more superior to conventional smears only with respect to lesser number of unsatisfactory smears, but considering the economic implications of LBC, conventional Pap is more feasible in our setting.

Entities:  

Keywords:  Cervical cancer screening; conventional Pap smear; human papillomavirus; liquid-based cytology

Mesh:

Year:  2018        PMID: 30147099     DOI: 10.4103/ijc.IJC_352_17

Source DB:  PubMed          Journal:  Indian J Cancer        ISSN: 0019-509X            Impact factor:   1.224


  12 in total

1.  Examining Primary Care Physicians' Intention to Perform Cervical Cancer Screening Services Using a Theory of Planned Behavior: A Structural Equation Modeling Approach.

Authors:  Zhiqing Hu; Yanjun Sun; Yuhao Ma; Kejin Chen; Ling Lv; Lingling Wang; Yuan He
Journal:  Front Public Health       Date:  2022-05-24

2.  Effect of crisis intervention nursing on perioperative psychological state and self-efficacy of patients undergoing laparoscopic radical hysterectomy.

Authors:  Yan Li; Sisi Chen; Mengjie Xu; Jiao Liu
Journal:  Am J Transl Res       Date:  2021-11-15       Impact factor: 4.060

Review 3.  A Review of Computational Methods for Cervical Cells Segmentation and Abnormality Classification.

Authors:  Teresa Conceição; Cristiana Braga; Luís Rosado; Maria João M Vasconcelos
Journal:  Int J Mol Sci       Date:  2019-10-15       Impact factor: 5.923

4.  Prevalence of Angiogenesis, Proliferation, and Apoptosis Markers of Cervical Cancer and Their Correlation with Clinicopathological Parameters.

Authors:  Anita Ramesh; R Vimal Chander; Chitra Srinivasan; Srinivasan Vengadassalapathy
Journal:  J Oncol       Date:  2020-11-12       Impact factor: 4.375

5.  Cervical screening in Western Kazakhstan: Liquid-based cytology 'Cell Scan' versus azur-eosin staining.

Authors:  Saule Balmagambetova; Giovanni Gabutti; Arip Koyshybaev; Cecilia Acuti Martellucci; Olzhas Urazayev; Kanshaiym Sakiyeva; Karlygash Bekova
Journal:  J Med Screen       Date:  2019-11-20       Impact factor: 2.136

6.  Automatic model for cervical cancer screening based on convolutional neural network: a retrospective, multicohort, multicenter study.

Authors:  Xiangyu Tan; Kexin Li; Jiucheng Zhang; Wenzhe Wang; Bian Wu; Jian Wu; Xiaoping Li; Xiaoyuan Huang
Journal:  Cancer Cell Int       Date:  2021-01-07       Impact factor: 5.722

Review 7.  Importance of Cytopathologic Diagnosis in Early Cancer Diagnosis in Resource-Constrained Countries.

Authors:  Kavita Yadav; Ian Cree; Andrew Field; Philippe Vielh; Ravi Mehrotra
Journal:  JCO Glob Oncol       Date:  2022-02

8.  Efficacy of careHPV™ human papillomavirus screening versus conventional cytology tests for the detection of precancerous and cancerous cervical lesions among women living with HIV-1 in Lao People's Democratic Republic.

Authors:  Phimpha Paboriboune; Keokedthong Phongsavan; Phetsamone Arounlangsy; Bruno Flaissier; Oukham Aphayarath; Prasit Phimmasone; Ketmala Banchongphanith; Mixi Xayaovong; Gonzague Jourdain; Anne-Marie Schott; Mitra Saadatian-Elahi; Laurent Magaud; Amna Klich; Nicole Ngo-Giang-Huong; Isabelle Heard; Muriel Rabilloud; Valentina Sanchez Picot; Christophe Longuet
Journal:  Cancer Med       Date:  2022-03-08       Impact factor: 4.711

9.  Systematic screening for cervical cancer in Dakar region: prevalence and correlation with biological and socio-demographic parameters.

Authors:  Dominique Diouf; Gora Diop; Cheikh Ahmadou Tidian Diarra; Aminata Issa Ngom; Khadija Niane; Moussa Ndiaye; Sidy Ka; Oumar Faye; Ahmadou Dem
Journal:  Infect Agent Cancer       Date:  2020-04-22       Impact factor: 2.965

10.  Current status of cervical cytology during pregnancy in Japan.

Authors:  Shunji Suzuki; Eijiro Hayata; Shin-Ichi Hoshi; Akihiko Sekizawa; Yoko Sagara; Masanobu Tanaka; Katsuyuki Kinoshita; Tadaichi Kitamura
Journal:  PLoS One       Date:  2021-01-07       Impact factor: 3.752

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.